# Noetic Fund

> Noetic Fund is a VC fund in Toronto backing Health Care and Biotechnology. See 24 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Toronto, Canada
- Total investments: 24
- Last investment: Feb 2024
- Lead investor: 42%
- Last updated: Aug 2026
- Website: http://noeticfund.com/

Noetic Fund is a venture fund launched by Grey House Partners GP Inc. to invest in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe. The company has proudly taken the North Star pledge and believes in the importance of stewarding this sector in the right way. It aims to nurture the scientific advancementof mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimizing our human experience.

## Contacts

5 contacts available for Noetic Fund. Shizune tracks 5 team members at Noetic Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/noetic-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 14 | 58% |
| Biotechnology | 10 | 42% |
| Medical | 7 | 29% |
| Pharmaceutical | 6 | 25% |
| Wellness | 5 | 21% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 29% |
| Seed | 5 | 21% |
| Venture - Series Unknown | 5 | 21% |
| Series B | 2 | 8% |
| Funding Round | 1 | 4% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 15 | 63% |
| Canada | 4 | 17% |
| United Kingdom | 2 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Craig Hippern | COO & CFO | 0 | — |
| Naseem Saloojee | Advisor | 0 | — |
| Sa'ad Shah | Managing Partner | 3 | — |
| Teja Mullapudi | Principal | 1 | — |
| West Stringfellow | Limited Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Numinus | Numinus combines time-tested holistic methods with the power of neuro-technology to bring holistic healthcare to patients. Payton Nyquvest and Stacey Wallin founded it in 2019, with its headquarters in Vancouver in Canada. | $4.5M | Post-IPO Equity | Feb 01, 2024 |  |
| Diamond Therapeutics | Diamond Therapeutics is a psychedelic drug development company based in Toronto. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic treatments that hold potential for use across a broad patient cohort — maximizingthe positive impact better drugs can have on the global mental health crisis. |  | Venture - Series Unknown | Apr 04, 2023 |  |
| Damona Pharmaceuticals | Damona Pharmaceuticals is a pre-clinical pharmaceutical company treats and prevents cognitive deficits in a variety of brain disorders and during aging. | $5.5M | Seed | Sep 26, 2022 |  |
| Vessel | Vessel is an at-home wellness tracker that helps in accessing, understanding, and optimizing health and wellness from the comfort of home. With Vessel, users can test 10 different health metrics in less than 10 minutes for around $10. Vessel works with some of the best doctors, nutritionists, and scientists to create its wellness cards and buildfood, supplement, and lifestyle recommendations tailored based on the results. A variety of membership plans enables one to see how diet, supplements, and lifestyle affect the body over time so users can start to feel and perform better. With Vessel, the science of feeling great fits in the palm of the hand. | $1.4M | Series A | Apr 18, 2022 |  |
| Apollo Neuroscience | Apollo is a wellness product, the first clinically validated wearable that actively helps the body recover from stress. Apollo Neuroscience is a wellness product not intended to treat psychiatric disorders such as generalized anxiety disorder, social anxiety disorder, and panic disorder. Apollo is not a substitute for professional medical care. | $15M | Series A | Mar 17, 2022 |  |
| Terran Biosciences | Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases. |  | Venture - Series Unknown | Jan 01, 2022 |  |
| Tactogen | Tactogen is a biopharma startup that develops empathogen medicines.The startup company offers drug discovery methods, novel molecules, and pharmaceutical preparations that focus on one goal: enabling safer take-home prescription empathogens.It is headquartered in Palo Alto, California in 2020 by Ph.D. neuroscientist Matthew Baggott and deeptechserial entrepreneur Luke Pustejovsky. |  | Seed | Jan 01, 2022 |  |
| Psygen Labs | Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. |  | Venture - Series Unknown | Jan 01, 2022 |  |
| Wake Network | Wake Network offers fungi and plant-based medicine. It leverages clinical research, wellness professionals, and technology to assemble a team focusing on the future of mental and holistic health. |  | Series A | Dec 14, 2021 |  |
| Delix Therapeutics | Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. | $70M | Series A | Sep 27, 2021 |  |

10 of 24 investments shown.

## Co-investors
- [PsyMed Ventures](https://shizune.co/investors/profile/psychedelic-medicine-syndicate) — VC Fund, 5 deals together
- [Presight Capital](https://shizune.co/investors/profile/presight-capital) — VC Fund, 3 deals together
- [Bail Capital](https://shizune.co/investors/profile/bail-capital) — VC Fund, 2 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 2 deals together
- [Innovation Works](https://shizune.co/investors/profile/innovation-works) — VC Fund, 2 deals together
- [Lionheart Ventures](https://shizune.co/investors/profile/lionheart-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Noetic Fund invest in?

Noetic Fund invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Seed stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Noetic Fund?

Public channels for Noetic Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Noetic Fund?

The team at Noetic Fund includes Craig Hippern (COO & CFO), Naseem Saloojee (Advisor) and Sa'ad Shah (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co